207 related articles for article (PubMed ID: 36419389)
1. The Managing Cancer and Living Meaningfully (CALM) Intervention Alleviates Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer by Modulating Pan-Immune-Inflammation Values.
Yao S; Ding K; Liu S; Zhang Q; Li W; Tang L; Yu S; Pang L; Yin X; Cheng H
Integr Cancer Ther; 2022; 21():15347354221140498. PubMed ID: 36419389
[TBL] [Abstract][Full Text] [Related]
2. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H
Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628
[TBL] [Abstract][Full Text] [Related]
3. Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.
Ding K; Zhang X; Zhao J; Zuo H; Bi Z; Cheng H
Integr Cancer Ther; 2020; 19():1534735420938450. PubMed ID: 32683997
[No Abstract] [Full Text] [Related]
4. Changes in cytokine levels in breast cancer patients with CRCI before or after CALM intervention.
Pang L; Bi Z; Jing Y; Yin X; Zhang X; Yao S; Zhao J; Cheng H
Am J Cancer Res; 2021; 11(11):5415-5427. PubMed ID: 34873469
[TBL] [Abstract][Full Text] [Related]
5. The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Yu S; Zhao J; Wang M; Cheng G; Li W; Tang L; Yao S; Pang L; Yin X; Jing Y; Cheng H
Front Med (Lausanne); 2022; 9():945433. PubMed ID: 36091709
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.
Yao S; Li W; Liu S; Cai Y; Zhang Q; Tang L; Yu S; Jing Y; Yin X; Cheng H
Cancer Med; 2023 Mar; 12(5):5209-5221. PubMed ID: 36200595
[TBL] [Abstract][Full Text] [Related]
7. In Regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors".
Zarrella GV; Braun SE
Integr Cancer Ther; 2023; 22():15347354231191706. PubMed ID: 37605802
[No Abstract] [Full Text] [Related]
8. Re: Response to In regard to Ding et al. 2020: "Managing Cancer and Living Meaningfully (CALM) Intervention on Chemotherapy Related Cognitive Impairment in Breast Cancer Survivors".
Cheng H; Ding K; Yao S
Integr Cancer Ther; 2023; 22():15347354231191715. PubMed ID: 37551862
[No Abstract] [Full Text] [Related]
9. Positive influence of managing cancer and living meaningfully (CALM) on fear of cancer recurrence in breast cancer survivors.
Wang M; Gan C; Zhao J; Li W; Yu S; Yao S; Tang L; Xu J; Cheng H
Am J Cancer Res; 2023; 13(7):3067-3079. PubMed ID: 37559986
[TBL] [Abstract][Full Text] [Related]
10. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H
Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458
[TBL] [Abstract][Full Text] [Related]
11. Association of immune inflammatory biomarkers with pathological complete response and clinical prognosis in young breast cancer patients undergoing neoadjuvant chemotherapy.
Li F; Wang Y; Dou H; Chen X; Wang J; Xiao M
Front Oncol; 2024; 14():1349021. PubMed ID: 38380360
[TBL] [Abstract][Full Text] [Related]
12. Effects of CALM intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer.
Zhao J; Wang M; Huang R; Xu J; Gan C; Yu S; Tang L; Yao S; Li W; Cheng H
Support Care Cancer; 2023 Jul; 31(7):447. PubMed ID: 37414980
[TBL] [Abstract][Full Text] [Related]
13. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
Juan Z; Chen J; Ding B; Yongping L; Liu K; Wang L; Le Y; Liao Q; Shi J; Huang J; Wu Y; Ma D; Ouyang W; Tong J
Eur J Cancer; 2022 Jan; 161():10-22. PubMed ID: 34896904
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Inflammatory and Immune Markers for Predicting the Prognosis of Patients with Stage IV Breast Cancer.
Yamanouchi K; Maeda S
Acta Med Okayama; 2023 Feb; 77(1):37-43. PubMed ID: 36849144
[TBL] [Abstract][Full Text] [Related]
15. Impact of the CALM intervention on breast cancer patients during the COVID-19 pandemic.
Pang L; Yao S; Li W; Jing Y; Yin X; Cheng H
Support Care Cancer; 2023 Jan; 31(2):121. PubMed ID: 36648574
[TBL] [Abstract][Full Text] [Related]
16. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
17. The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors.
Zhang X; Yao S; Wang M; Yin X; Bi Z; Jing Y; Cheng H
J Oncol; 2022; 2022():1012813. PubMed ID: 35712124
[TBL] [Abstract][Full Text] [Related]
18. Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Duivon M; Lequesne J; Di Meglio A; Pradon C; Vaz-Luis I; Martin AL; Everhard S; Broutin S; Rigal O; Bousrih C; Lévy C; Lerebours F; Lange M; Joly F
Breast Cancer Res; 2024 Jun; 26(1):93. PubMed ID: 38840166
[TBL] [Abstract][Full Text] [Related]
19. Effects of the CALM intervention on resilience in Chinese patients with early breast cancer: a randomized trial.
Liu S; Huang R; Li A; Yu S; Yao S; Xu J; Tang L; Li W; Gan C; Cheng H
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18005-18021. PubMed ID: 37980293
[TBL] [Abstract][Full Text] [Related]
20. A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial.
Van der Gucht K; Melis M; Ahmadoun S; Gebruers A; Smeets A; Vandenbulcke M; Wildiers H; Neven P; Kuppens P; Raes F; Sunaert S; Deprez S
Trials; 2020 Mar; 21(1):290. PubMed ID: 32293533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
